A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania

Trial Profile

A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Apr 2010

At a glance

  • Drugs Olanzapine (Primary)
  • Indications Trichotillomania
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Apr 2010 Results were published early online in the Journal of Clinical Psychiatry.
    • 27 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top